VCAM1 and schistosomiasis: Of note, VCAM-1 has been identified as a significant contributor to the pathogenesis of schistosomiasis (44–47), and endothelial cell treatment with an anti-VCAM-1 monoclonal antibody reduces the egg adhesion to these cells (47).